Healthcare Data News – Page 134 – News from the healthcare data industry

Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD

January 20, 2022January 25, 2022

Abstract Background: The CARD study demonstrated superiority of cabazitaxel over abiraterone/enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) who received prior docetaxel and progressed ≤12 months on the alternative androgen-receptor-targeted agent (ARTA). The objective was to compare characteristics and treatment patterns of patients from a real-world dataset with the CARD…

Competitor News, RWE Study

Analysis Group Researchers Demonstrate a Highly Effective New Real-World Data Generation Method

January 19, 2022January 25, 2022

BOSTON, Jan. 19, 2022 /PRNewswire/ — Analysis Group, a global leader in health economics and outcomes research (HEOR), announced that its groundbreaking method for generating real-world data (RWD) has proven both effective and repeatable. Following rigorous peer review, JAMA Dermatology published a paper introducing the new method, which was used to study dupilumab patient outcomes,…

Competitor News, HR

Health Gorilla Makes a Splash Hire in Pursuit of Their QHIN Designation

January 19, 2022January 25, 2022

Palo Alto, California, Jan. 19, 2022 (GLOBE NEWSWIRE) — Health Gorilla, leading Health Information Network in the United States, announced today their hiring of Carol Allis as Chief Compliance Officer. Health Gorilla declared their intention to become a Qualified Health Information Network (QHIN) on October 6th, 2021 and has brought…

Collaborations, Competitor News, Data Partnership, Ethics

Truveta and LexisNexis Risk Solutions Partner to Advance Health Equity and Health Research Quality

January 18, 2022April 4, 2022

REDMOND, Wash. and ATLANTA, Jan. 18, 2022 (GLOBE NEWSWIRE) — Truveta, the health system-led company with a vision of saving lives with data, and the Health Care business of LexisNexis Risk Solutions, the leading provider of healthcare optimization data and patient linking technology, today announced a strategic partnership that will improve…

Competitor News, COVID-19, RWE Study

New nference Study Identifies Distinctive Characteristics of SARS-CoV-2 Variants Using Genomic Diversification

January 18, 2022

Results validate company’s methodology and provide insight about the rapid evolution of future variants of concern January 18, 2022 08:45 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–nference, an AI-driven health technology company, today announced the publication of a preprint study in medRxiv, validating the company’s methodology for characterizing SARS-CoV-2 evolution. The…

Competitor News, HR

M2GEN Expands Leadership Team, Appointing Daniel Elgort, Ph.D. as Chief Data and Analytics Officer and May Yoon as Chief People Officer

January 18, 2022

TAMPA, Fla., Jan. 18, 2022 /PRNewswire/ — M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry leading data and analytics, today announced that it has expanded its executive team with the appointments of Daniel Elgort, Ph.D., as Chief Data and Analytics Officer and May Yoon as Chief People Officer. The two appointments strengthen M2GEN’s…

Industry News

Addressing 4 Common Roadblocks When Using RWD in Regulatory Submissions

January 18, 2022January 25, 2022

January 18, 2022Scott Swain, PhD, MPH Since 2016, the 21st Century Cures Act has required the Food and Drug Administration (FDA) to consider the utility of any real-world evidence (RWE) study submitted by a sponsor in support of an efficacy claim for a medical product. However, even as the FDA…

AI, Industry News

Applying AI to Real-World Data to Improve Pharmaceutical Development

January 18, 2022January 18, 2022

January 18, 2022 | Trends from the Trenches—Xiong Sean Liu is a Director at Novartis where he has been working to make inroads for AI in pharma. In Liu’s view, AI as a technology is already successful, but he also believes it is still in its early days for healthcare and there…

Industry News

WHAT IS SYNTHETIC DATA, AND WHY WILL IT BE SO IMPORTANT?

January 14, 2022January 17, 2022

January 14, 2022 By Joseph Moss, International Banker We are now comfortably in the era of data, with more and more of it being generated with every passing year. And looking forward, it seems this rapidly expanding universe will only balloon further—and at an astonishing rate. But does the proliferation of…

Partner and Collaborator News, RWE Study

Between the Lines™ Podcast: Incorporating Real-World Evidence into Clinical Decisions in NSCLC

January 14, 2022January 17, 2022

Lyudmila Bazhenova, MD, and Federico Albrecht, MD, detailed the importance of using real-world evidence to inform treatment for patients with EGFR-mutated non–small cell lung cancer.https://embeds.audioboom.com/posts/8012579/embed/v4 As part of its Between the Lines™ video series, CancerNetwork® spoke with Lyudmila Bazhenova, MD, a professor of medicine at the University of California San…